IPA (immunoprecise.com) Bozor qiymatining balans qiymatiga nisbati

immunoprecise.com (IPA) kompaniyasining rasmiy ramzlari

ImmunoPrecise Antibodies (IPA) global logistik uzilishlar va patent murakkabliklariga duch kelmoqda. Mijozlarning autsorsing xarajatlarining kamayishi va shiddatli raqobat daromadliilikka salbiy ta'sir ko'rsatmoqda, garchi AI yechimlarining joriy etilishi investorlarning ishonchini mustahkamlayotgan bo'lsa-da. Kompaniyaning bozor qiymatining buxgalteriya qiymatiga nisbati joriy treyderlar kayfiyatini aks ettirmoqda, bunda 5.69 darajasi aktivning haddan tashqari sotib olingan holatini baholash uchun muhim mezon bo'lib xizmat qilmoqda.

immunoprecise.com (IPA) - Bozor kapitallashuvining balans qiymatiga nisbati 04.07.2022dan 04.09.2025gacha

ImmunoPrecise Antibodies (IPA) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi immunoprecise.com|IPA - Investitsiya uylarining umumiy prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati ImmunoPrecise|IPA - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati ImmunoPrecise Antibodies|IPA - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati immunoprecise.com|IPA - Kompaniya aktivlarining umumiy hajmi
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati ImmunoPrecise Antibodies|IPA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati immunoprecise.com|IPA - Kompaniyaning umumiy qarzi|Qarzning balans qiymatiga nisbati ImmunoPrecise
Kompaniyaning asosiy tahlili:ImmunoPrecise Antibodies Ltd - IPA
immunoprecise.com tayyor mahsulotlari

Ekologik toza virtual antitanalar testlash usullarini joriy etuvchi ImmunoPrecise Antibodies (IPA) uchun kitob qiymatiga nisbat koeffitsiyenti uning texnologik salohiyatining bozor bahosini aks ettiradi. Ushbu ko'rsatkich joriy bozor kapitalizatsiyasini aksiyadorlar kapitalining sof qiymati bilan solishtiradi. Hisob-kitob barcha aksiyalarning bozor qiymatini majburiyatlar ayirilgan kitob aktivlari qiymatiga bo'lishga asoslangan. Past qiymatlar aktivlarning yetarlicha baholanmaganligini yoki ichki xatarlarni ko'rsatishi mumkin. Investorlar uchun ushbu koeffitsiyentni kompaniyaning ESG innovatsiyalari rivojlanish sur'ati bilan bog'liqligini aniqlash juda muhimdir.

Toʻgʻridan-toʻgʻri raqobatchilar

Bozor kapitallashuvining balans qiymatiga nisbati Tempus Labs|QGEN (qiagen.com) - Kapitallashuvning balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati Repligen Corp|Bozor kapitallashuvining balans qiymatiga nisbati RNA|Bozor kapitallashuvining balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS|ultragenyx.com - Balans qiymatiga nisbatan bozor kapitallashuvi|BEAM: Bozor qiymatining balans qiymatiga nisbati|SRPT: Kapitallashuvning sof aktivlarga nisbati|TWST (Twist Bio) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati 10x|NTLA (Intellia Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati STOK|Bozor qiymatining balans qiymatiga nisbati BioLife Solutions BLFS|Kapitallashuvning balans qiymatiga nisbati WVE (Wave Life Sciences Ltd)|MAZE: Bozor qiymatining balans qiymatiga nisbati|Sionna Corp - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Prime Medicine, Inc.|TSHA: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati uniQure QURE|MeiraGTx Holdings (MGTX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati RGNX (Regenxbio)|Bozor qiymatining balans qiymatiga koeffitsiyenti Solid Corp|Bozor kapitallashuvining balans qiymatiga nisbati OCGN (Ocugen, Inc.)|Kapitallashuvning sof aktivlarga nisbati pacb.com (PACB)|Bozor kapitallashuvining balans qiymatiga nisbati BNTC|Design Therapeutics Inc - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati RCKT (Rocket Pharmaceuticals Inc)|FDMT - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati LXEO|Bozor qiymatining balans qiymatiga koeffitsiyenti Korro Bio|EDIT - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Silence Therapeutics PLC|Bozor kapitallashuvining balans qiymatiga nisbati PRQR|Bozor kapitallashuvining balans qiymatiga nisbati CDXS (codexis.com)|SGMO - Bozor qiymatining balans qiymatiga nisbati|NAUT - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Metagenomi MGX|DTIL - Bozor kapitallashuvining balans qiymatiga multiplikatori|generationbio.com - Bozor kapitallashuvining balans qiymatiga nisbati|Boundless Bio Inc (BOLD) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati Exicure Inc.|Bozor qiymatining balans qiymatiga nisbati IMNN|Phio Pharmaceuticals - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti mustangbio.com (MBIO)|RNAZ - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Bionano Genomics Inc. BNGO|Bozor kapitallashuvining balans qiymatiga nisbati APDN (Applied DNA Sciences)|BLUE - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati OMGA|OMIC (Singular Genomics Systems, Inc.) - Bozor qiymatining balans qiymatiga koeffitsiyenti|RGLS: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Syros Pharmaceuticals, Inc|TBIO (Telesis Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi TCON (traconpharma.com)|Unity Biotechnology, Inc. (UBX) - Bozor qiymatining balans qiymatiga nisbati